Displaying 1 - 20 of 43
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)
The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
Concurring Statement of Commissioner Andrew N. Ferguson Joined by Commissioner Melissa Holyoak Regarding the Second Pharmacy Benefit Managers Interim Staff Report
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
FTC Announces Tentative Agenda for January 14 Open Commission Meeting
Statement of Chair Lina M. Khan In the Matter of Cooperativa de Farmacias Puertoriqueñas
FTC Approves Modification of Cooperativa De Farmacias Puertorriqueñas Final Commission Order
Statement of Commissioner Melissa Holyoak In the Matter of Cooperativa De Farmacias Puertorriqueña
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
FTC Seeks Public Comments on Cooperativa De Farmacias Puertorriqueñas Request to Modify Final Commission Order
FTC Announces Tentative Agenda for August 1 Open Commission Meeting
Statement of Chair Lina M. Khan Joined by Commissioners Alvaro M. Bedoya & Rebecca Kelly Slaughter Regarding the Pharmacy Benefit Managers Interim Staff Report
FTC Releases Interim Staff Report on Prescription Drug Middlemen
Displaying 1 - 20 of 43